China Isotope & Radiation Corporation (HKG:1763)
Hong Kong
· Delayed Price · Currency is HKD 18.89
-0.02 (-0.11%)
Apr 29, 2026, 4:08 PM HKT
China Isotope & Radiation Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 7,188 | 7,575 | 6,635 | 6,154 | 5,144 | Upgrade
|
| Revenue Growth (YoY) | -5.11% | 14.16% | 7.82% | 19.63% | 20.34% | Upgrade
|
| Cost of Revenue | 3,566 | 3,892 | 3,153 | 2,636 | 1,902 | Upgrade
|
| Gross Profit | 3,622 | 3,683 | 3,482 | 3,518 | 3,242 | Upgrade
|
| Selling, General & Admin | 2,330 | 2,329 | 2,406 | 2,365 | 2,320 | Upgrade
|
| Research & Development | 301.92 | 300.29 | 306.05 | 300.51 | 196.21 | Upgrade
|
| Other Operating Expenses | -74.25 | -72.25 | -50.33 | -53.81 | -28.36 | Upgrade
|
| Operating Expenses | 2,602 | 2,603 | 2,733 | 2,643 | 2,499 | Upgrade
|
| Operating Income | 1,019 | 1,080 | 749.68 | 874.88 | 742.85 | Upgrade
|
| Interest Expense | -64.05 | -47.21 | -34.83 | -33.66 | -34.04 | Upgrade
|
| Interest & Investment Income | 37.38 | 34.09 | 36.57 | 51.69 | 30.99 | Upgrade
|
| Earnings From Equity Investments | 16.55 | 7.27 | 16.98 | 42.17 | 60.66 | Upgrade
|
| Currency Exchange Gain (Loss) | -7.82 | -9.44 | -4.39 | -13.29 | -1.65 | Upgrade
|
| Other Non Operating Income (Expenses) | -5.83 | - | - | - | - | Upgrade
|
| EBT Excluding Unusual Items | 995.51 | 1,065 | 764.01 | 921.78 | 798.81 | Upgrade
|
| Gain (Loss) on Sale of Investments | -0.8 | -19.34 | - | - | 4.55 | Upgrade
|
| Gain (Loss) on Sale of Assets | 9.56 | -0.2 | 158.42 | -1.12 | -0.68 | Upgrade
|
| Asset Writedown | -0.22 | -0 | - | - | - | Upgrade
|
| Other Unusual Items | 0.08 | 0.16 | - | 0.13 | - | Upgrade
|
| Pretax Income | 1,004 | 1,045 | 922.44 | 920.79 | 802.68 | Upgrade
|
| Income Tax Expense | 339.58 | 165.69 | 146.31 | 165.56 | 129.64 | Upgrade
|
| Earnings From Continuing Operations | 664.54 | 879.54 | 776.13 | 755.24 | 673.04 | Upgrade
|
| Minority Interest in Earnings | -337.12 | -472.89 | -405.16 | -362.96 | -337.29 | Upgrade
|
| Net Income | 327.43 | 406.65 | 370.97 | 392.28 | 335.75 | Upgrade
|
| Net Income to Common | 327.43 | 406.65 | 370.97 | 392.28 | 335.75 | Upgrade
|
| Net Income Growth | -19.48% | 9.62% | -5.43% | 16.84% | 57.20% | Upgrade
|
| Shares Outstanding (Basic) | 320 | 320 | 320 | 320 | 320 | Upgrade
|
| Shares Outstanding (Diluted) | 320 | 320 | 320 | 320 | 320 | Upgrade
|
| EPS (Basic) | 1.02 | 1.27 | 1.16 | 1.23 | 1.05 | Upgrade
|
| EPS (Diluted) | 1.02 | 1.27 | 1.16 | 1.23 | 1.05 | Upgrade
|
| EPS Growth | -19.48% | 9.62% | -5.43% | 16.84% | 57.20% | Upgrade
|
| Free Cash Flow | -28.43 | -889.71 | -812.66 | 286.74 | 366.59 | Upgrade
|
| Free Cash Flow Per Share | -0.09 | -2.78 | -2.54 | 0.90 | 1.15 | Upgrade
|
| Dividend Per Share | 0.307 | 0.381 | 0.313 | 0.441 | 0.378 | Upgrade
|
| Dividend Growth | -19.48% | 21.81% | -28.95% | 16.62% | 109.59% | Upgrade
|
| Gross Margin | 50.39% | 48.62% | 52.48% | 57.16% | 63.03% | Upgrade
|
| Operating Margin | 14.18% | 14.26% | 11.30% | 14.22% | 14.44% | Upgrade
|
| Profit Margin | 4.55% | 5.37% | 5.59% | 6.38% | 6.53% | Upgrade
|
| Free Cash Flow Margin | -0.40% | -11.75% | -12.25% | 4.66% | 7.13% | Upgrade
|
| EBITDA | 1,238 | 1,286 | 972.91 | 1,058 | 901.43 | Upgrade
|
| EBITDA Margin | 17.22% | 16.97% | 14.66% | 17.19% | 17.52% | Upgrade
|
| D&A For EBITDA | 218.34 | 205.76 | 223.23 | 182.76 | 158.58 | Upgrade
|
| EBIT | 1,019 | 1,080 | 749.68 | 874.88 | 742.85 | Upgrade
|
| EBIT Margin | 14.18% | 14.26% | 11.30% | 14.22% | 14.44% | Upgrade
|
| Effective Tax Rate | 33.82% | 15.85% | 15.86% | 17.98% | 16.15% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.